These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 37685789)

  • 1. Combination Biologic Therapy with Mepolizumab and Dupilumab for Severe Eosinophilic Granulomatosis with Polyangiitis and Chronic Rhinosinusitis with Nasal Polyp.
    Nakamura Y; Kikumoto N; Takeuchi H; Kimura T; Nakamori M; Fujiwara K
    Yonago Acta Med; 2024 May; 67(2):157-162. PubMed ID: 38803595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence.
    Caminati M; Micheletto C; Norelli F; Olivieri B; Ottaviano G; Padoan R; Piacentini G; Schiappoli M; Senna G; Menzella F
    Expert Opin Biol Ther; 2024; 24(1-2):15-23. PubMed ID: 38197326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilia and Kidney Disease: More than Just an Incidental Finding?
    Gauckler P; Shin JI; Mayer G; Kronbichler A
    J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30544782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of continued treatment with dupilumab in patients with type 2 inflammatory disease who developed eosinophilic pneumonia: 3 case reports.
    Hamakawa M; Tanaka A; Tokioka F; Ishida T
    Respirol Case Rep; 2024 Jun; 12(6):e01412. PubMed ID: 38872913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful combination therapy of mepolizumab and dupilumab in a patient with EGPA: a future therapeutic option?
    Martins-Martinho J; Pereira da Costa R; Abreu T; Ponte C
    Rheumatol Adv Pract; 2024; 8(3):rkae093. PubMed ID: 39131697
    [No Abstract]   [Full Text] [Related]  

  • 6. Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible.
    Zhao B; Zheng H; Yang T; Zheng R
    Allergy Asthma Proc; 2023 Jan; 44(1):59-63. PubMed ID: 36719697
    [No Abstract]   [Full Text] [Related]  

  • 7. The Role of T Helper Type 2 (Th2) Cytokines in the Pathogenesis of Eosinophilic Granulomatosis with Polyangiitis (eGPA): an Illustrative Case and Discussion.
    Milne ME; Kimball J; Tarrant TK; Al-Rohil RN; Leverenz DL
    Curr Allergy Asthma Rep; 2022 Nov; 22(11):141-150. PubMed ID: 36103081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Peripheral Blood Eosinophil Counts and Risk of Eosinophilic Granulomatosis with Polyangiitis Onset after Initiation of Dupilumab Administration in Adult Patients with Asthma.
    Kushima Y; Shimizu Y; Hoshi H; Arai R; Ikeda N; Nakamura Y; Masawa M; Okutomi H; Yazawa N; Chibana K; Takemasa A; Niho S
    J Clin Med; 2023 Sep; 12(17):. PubMed ID: 37685789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report.
    Suzaki I; Tanaka A; Yanai R; Maruyama Y; Kamimura S; Hirano K; Kobayashi H
    BMC Pulm Med; 2023 Apr; 23(1):130. PubMed ID: 37076824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
    Wechsler ME; Klion AD; Paggiaro P; Nair P; Staumont-Salle D; Radwan A; Johnson RR; Kapoor U; Khokhar FA; Daizadeh N; Chen Z; Laws E; Ortiz B; Jacob-Nara JA; Mannent LP; Rowe PJ; Deniz Y
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2695-2709. PubMed ID: 35636689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbation of Eosinophilic Granulomatosis With Polyangiitis After Administering Dupilumab for Severe Asthma and Eosinophilic Rhinosinusitis With Nasal Polyposis.
    Tanaka S; Tsuji T; Shiotsu S; Yuba T; Hiraoka N
    Cureus; 2022 May; 14(5):e25218. PubMed ID: 35747049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Asthma Where Eosinophilic Granulomatosis with Polyangiitis Became Apparent after the Discontinuation of Dupilumab.
    Ikeda M; Ohshima N; Kawashima M; Shiina M; Kitani M; Suzukawa M
    Intern Med; 2022 Mar; 61(5):755-759. PubMed ID: 34393172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune response reflects disease activity in eosinophilic granulomatosis with polyangiitis.
    Tsurikisawa N; Oshikata C; Watanabe M; Tsuburai T; Kaneko T; Saito H
    Clin Exp Allergy; 2018 Oct; 48(10):1305-1316. PubMed ID: 29908086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution in Endoscopic Sinus Surgery: The Adjuvant Role of Reboot Surgery in Patients with Uncontrolled Nasal Symptoms of Eosinophilic Granulomatosis with Polyangiitis.
    Pirola F; Giunta G; Muci G; Giombi F; Nappi E; Grizzi F; Heffler E; Paoletti G; Canonica GW; Mercante G; Spriano G; Schroeder JW; Malvezzi L
    J Pers Med; 2023 Apr; 13(4):. PubMed ID: 37109033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Care for Patients with Type-2 Chronic Rhinosinusitis.
    Giunta G; Pirola F; Giombi F; Muci G; Pace GM; Heffler E; Paoletti G; Puggioni F; Cerasuolo M; Ferreli F; Salamanca F; Mercante G; Spriano G; Canonica GW; Malvezzi L
    J Pers Med; 2023 Mar; 13(4):. PubMed ID: 37109003
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.